Covid-Cancer Rapid Response Award
During and after treatment, people with cancer can experience physical, psychological, and social concerns that can negatively affect quality of life. Unfortunately, the Covid-19 pandemic has not only exacerbated existing challenges for patient care and outcomes, but also created new ones. While there is optimism that public health measures and vaccination will reduce the burden for wider society, it is anticipated that Covid will affect these aspects of cancer care for several years to come.
To address the urgent needs of people affected by cancer against the backdrop of Covid-related challenges, the Irish Cancer Society in collaboration with the National Cancer Control Programme (NCCP) will shortly be launching the Covid-Cancer Rapid Response Award.
Aim and funding
The aim of this award is to help identify evidence-based mitigations for the burdens brought about by Covid on people living with or beyond cancer.
Funding of €75,000 has been allocated to each of three priority areas:
- Mitigating the impact of Covid-19 on the psycho-social needs of people affected by cancer (non-palliative).
- Mitigating the impact of Covid-19 on people with cancer receiving palliative care, those with metastatic/advanced disease, or their family/caregivers.
- Mitigate the impact of Covid-19 on the general survivorship needs of people affected cancer (other than the palliative and psycho-social needs addressed in priority areas 1 and 2).
Applicants may submit proposals that address one (max funding €75,000), two (max funding €150,000), or three (max funding €225,000) priority areas.
Funding is available for awards of six to 18 months duration. While not a requirement, preference will be given to applications that leverage co-investments from other health agencies, companies, or funding agencies to increase the speed and/or scope of the research.
|Applications open||11 June 2021|
|Application deadline||11 August 2021 - 3pm|
|Outcome announced||September 2021|
|Award start||Q4 2021|
Please note that dates are subject to change.